Kyle Michel has a decade of industry experience in immuno-oncology drug discovery and development. During his time at Biothera Pharmaceuticals he was responsible for creating carbohydrate immunomodulators and antibody drug conjugates. With his background in carbohydrate chemistry he now manages the quality control program of Imprime PGG conducting release and stability testing.
Kyle received a B.A. in chemistry from the University of Minnesota, Morris.